Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Benefits And Finance topic
No spam. Unsubscribe anytime.
Council approves $2.5M transfer to risk fund after debate over rising health claims, GLP-1 coverage
Summary
Council voted to transfer $2.5 million from the general fund to the risk fund to cover higher-than-expected healthcare claims. Members asked whether coverage of GLP-1 weight-loss drugs was contributing; city staff said some coverage exists but noted HIPAA limits on details.
Allentown City Council approved Bill 101, a $2.5 million transfer from the general fund to the risk fund to cover healthcare claims, prescription benefits and other employee medical costs for the remainder of the year.
Staff explained that the city is self-insured and that a small number of high claims this year have driven unexpectedly large expenditures. During debate, a councilor questioned whether coverage of GLP-1 weight-loss drugs (referred to in the meeting as ‘‘diet injections’’) was contributing to the higher claims and suggested individual claims could be in the $10,000–$20,000 range. City staff replied, "I don't believe that's accurate information" regarding the councilor's characterization, and added, "Without without violating HIPAA, we do cover the cost some portion of the cost associated with the use of GLP 1 drugs," indicating the city provides some coverage under existing employee agreements but that specifics about individual claims are protected by health‑privacy rules.
The council vote met the procedural threshold described in the charter for immediate effect when coupled with the mayor's signature, and the clerk recorded unanimous affirmative votes among members present. The transfer will be used by finance/risk-management staff to pay pending healthcare claims and related costs while the city continues to monitor claim drivers and budget impacts.
